PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia
Author:
Affiliation:
1. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
2. Shanghai Medical college, Fudan University, Shanghai, China.
Publisher
XMLink
Subject
Obstetrics and Gynecology,Oncology,General Medicine
Link
https://ejgo.org/pdf/10.3802/jgo.2023.34.e53
Reference40 articles.
1. International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
2. Risk Factors for Young Premenopausal Women With Endometrial Cancer
3. Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
4. Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
5. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fertility-Sparing treatment in MSI-H/MMRd endometrial carcinoma or atypical endometrial Hyperplasia: A systematic review and Meta-Analysis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09
2. Integrated machine learning identifies a cellular senescence-related prognostic model to improve outcomes in uterine corpus endometrial carcinoma;Frontiers in Immunology;2024-06-27
3. Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment;Frontiers in Endocrinology;2024-06-11
4. Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer;Gynecologic Oncology;2024-06
5. Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors;European Journal of Cancer;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3